Overview

Postoperative Analgesia After Laparoscopic Living Donor Nephrectomy

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of the study is to investigate if perioperative administration of pregabalin vil reduce postoperative pain and the postoperative need for intravenous opioids compared with todays standard treatment which consist of paracetamol, corticoids and ketobemidone. In addition potential sideeffects as sedation and effect on cognitive function will be recorded.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Pregabalin
Criteria
Inclusion Criteria:

- >18, < 75 years

- healthy patients accepted for laparoscopic living donor nephrectomy

Exclusion Criteria:

- not familiar to the Norwegian language (spoken and written)

- allergic to one or more of the medication given in the study